Patent ID: 8642541
Filing Date: 2014-02-04
Classification: A61K,A61P,C07K

Abstract:
1. A compound having the formula R 1 —X—Z—R 2 wherein R R X is a peptide which has the formula I: or differs from formula I at up to 4 of the following positions whereby, if different from formula I: the residue at position 20 is selected from: Gln, Glu; the residue at position 23 is: Val; the residue at position 24 is selected from: Gln, Lys; the residue at position 27 is: Met; the residue at position 28 is selected from: Asn, Arg; and the residue at position 29 is: Thr; and Z is absent or a peptide sequence of 1-20 amino acid units selected from the group consisting of Ala, Leu, Ser, Thr, Tyr, Cys, Glu, Lys, Arg, Dbu, Dpr and Orn; or a pharmaceutically acceptable salt thereof.